Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

24 November 2025 : Clinical Research  

Perforin Expression and Natural Killer-Cell Proportion as Biomarkers in Secondary Hemophagocytic Lymphohistiocytosis

Jujuan Wang EF 1, Xin Li BE 2, Limin Duan BC 1, Guangli Yin CG 1, Xin Gao AF 1, Hongxia Qiu G 1, Ji Xu AD 1*, Tian Tian ORCID logo AB 1

DOI: 10.12659/MSM.950615

Med Sci Monit 2025; 31:e950615

Figure 2 Alterations in cytotoxic lymphocyte subsets and perforin expression in patients with newly diagnosed secondary hemophagocytic lymphohistiocytosis (sHLH) and complete response sHLH (CR-sHLH). Proportions of circulating CD8+ T cells (TCRαβ+CD8+CD56−), natural killer (NK) cells (TCRαβ−CD56+), and CD56+ T cells (TCRαβ+CD56+) (A), and the percentage of perforin-positive cells within each respective lymphocyte subset (B) were compared between 19 newly diagnosed sHLH patients and 10 healthy controls. The proportion of NK cells was decreased, and the percentage of perforin-positive CD56+ T cells was elevated in sHLH patients, compared with healthy controls (P=0.006 and P=0.035, respectively). Lymphocyte subset proportions (C) and the percentage of perforin-positive cells within these subsets (D) were compared between 19 newly diagnosed sHLH patients and 6 CR-sHLH patients. The proportion of CD8+ T cells was significantly lower in CR-sHLH patients than in newly diagnosed sHLH patients (P=0.023). Data are presented as scatter plots with each point representing an individual patient; horizontal lines indicate the median and interquartile range. Statistical significance between independent groups was determined using the Mann-Whitney U test. Figure created with GraphPad Prism v8.0.

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750